DD151748A5 - Verfahren zur herstellung von trijodierten 5-aminoisophtalsaeure-derivaten - Google Patents
Verfahren zur herstellung von trijodierten 5-aminoisophtalsaeure-derivaten Download PDFInfo
- Publication number
- DD151748A5 DD151748A5 DD80222179A DD22217980A DD151748A5 DD 151748 A5 DD151748 A5 DD 151748A5 DD 80222179 A DD80222179 A DD 80222179A DD 22217980 A DD22217980 A DD 22217980A DD 151748 A5 DD151748 A5 DD 151748A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- bis
- acid
- lower alkyl
- methyl
- theory
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title description 15
- 238000000034 method Methods 0.000 title description 10
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 8
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 7
- 239000001257 hydrogen Substances 0.000 claims abstract description 7
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 6
- 125000003748 selenium group Chemical group *[Se]* 0.000 claims abstract description 6
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 6
- 239000011593 sulfur Substances 0.000 claims abstract description 6
- 125000004430 oxygen atom Chemical group O* 0.000 claims abstract description 5
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 3
- KBZFDRWPMZESDI-UHFFFAOYSA-N 5-aminobenzene-1,3-dicarboxylic acid Chemical class NC1=CC(C(O)=O)=CC(C(O)=O)=C1 KBZFDRWPMZESDI-UHFFFAOYSA-N 0.000 claims abstract 2
- -1 tetracarboxylic acid tetrachloride Chemical class 0.000 claims description 67
- 229910052740 iodine Inorganic materials 0.000 claims description 8
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002872 contrast media Substances 0.000 abstract description 33
- 150000001875 compounds Chemical class 0.000 abstract description 18
- 239000000126 substance Substances 0.000 abstract description 16
- 230000000144 pharmacologic effect Effects 0.000 abstract description 2
- 101100269618 Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) aliA gene Proteins 0.000 abstract 2
- 101100242909 Streptococcus pneumoniae (strain ATCC BAA-255 / R6) pbpA gene Proteins 0.000 abstract 1
- 101100439974 Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) clpE gene Proteins 0.000 abstract 1
- 101150109310 msrAB1 gene Proteins 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 51
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 42
- 239000000243 solution Substances 0.000 description 34
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 32
- 238000000354 decomposition reaction Methods 0.000 description 27
- KPZGRMZPZLOPBS-UHFFFAOYSA-N 1,3-dichloro-2,2-bis(chloromethyl)propane Chemical compound ClCC(CCl)(CCl)CCl KPZGRMZPZLOPBS-UHFFFAOYSA-N 0.000 description 20
- 239000002253 acid Substances 0.000 description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 12
- 230000002378 acidificating effect Effects 0.000 description 11
- 238000002844 melting Methods 0.000 description 11
- 230000008018 melting Effects 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 125000004432 carbon atom Chemical group C* 0.000 description 10
- 150000001768 cations Chemical class 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- ODJQKYXPKWQWNK-UHFFFAOYSA-N 3,3'-Thiobispropanoic acid Chemical compound OC(=O)CCSCCC(O)=O ODJQKYXPKWQWNK-UHFFFAOYSA-N 0.000 description 9
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 9
- 150000001450 anions Chemical class 0.000 description 9
- 150000002500 ions Chemical class 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 9
- 239000003490 Thiodipropionic acid Substances 0.000 description 8
- 239000012043 crude product Substances 0.000 description 8
- 238000001556 precipitation Methods 0.000 description 8
- 235000019303 thiodipropionic acid Nutrition 0.000 description 8
- SWNDUEDARACPMW-UHFFFAOYSA-N 1-(methylamino)propane-1,1-diol Chemical compound CCC(O)(O)NC SWNDUEDARACPMW-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 210000004324 lymphatic system Anatomy 0.000 description 7
- 238000001226 reprecipitation Methods 0.000 description 7
- FBJVWRITWDYUAC-UHFFFAOYSA-N 5-amino-2,4,6-triiodobenzene-1,3-dicarbonyl chloride Chemical compound NC1=C(I)C(C(Cl)=O)=C(I)C(C(Cl)=O)=C1I FBJVWRITWDYUAC-UHFFFAOYSA-N 0.000 description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000007112 amidation reaction Methods 0.000 description 6
- 229940039231 contrast media Drugs 0.000 description 6
- 239000011630 iodine Substances 0.000 description 6
- 210000001165 lymph node Anatomy 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 210000001365 lymphatic vessel Anatomy 0.000 description 5
- 230000003204 osmotic effect Effects 0.000 description 5
- 235000011121 sodium hydroxide Nutrition 0.000 description 5
- FQAXLTARZOJBPJ-UHFFFAOYSA-N 2,4,6-triiodobenzene-1,3-dicarbonyl chloride Chemical compound ClC(=O)C1=C(I)C=C(I)C(C(Cl)=O)=C1I FQAXLTARZOJBPJ-UHFFFAOYSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 230000009435 amidation Effects 0.000 description 4
- 238000002583 angiography Methods 0.000 description 4
- 229960002255 azelaic acid Drugs 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 4
- DLLMHEDYJQACRM-UHFFFAOYSA-N 2-(carboxymethyldisulfanyl)acetic acid Chemical compound OC(=O)CSSCC(O)=O DLLMHEDYJQACRM-UHFFFAOYSA-N 0.000 description 3
- DTPJJCQDHGWTNX-UHFFFAOYSA-N 3-[[2-carboxyethyl(dimethyl)silyl]oxy-dimethylsilyl]propanoic acid Chemical compound OC(=O)CC[Si](C)(C)O[Si](C)(C)CCC(O)=O DTPJJCQDHGWTNX-UHFFFAOYSA-N 0.000 description 3
- JEZJSNULLBSYHV-UHFFFAOYSA-N 5-amino-2,4,6-triiodobenzene-1,3-dicarboxylic acid Chemical compound NC1=C(I)C(C(O)=O)=C(I)C(C(O)=O)=C1I JEZJSNULLBSYHV-UHFFFAOYSA-N 0.000 description 3
- BAQCROVBDNBEEB-UBYUBLNFSA-N Metrizamide Chemical compound CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C(=O)N[C@@H]2[C@H]([C@H](O)[C@@H](CO)OC2O)O)=C1I BAQCROVBDNBEEB-UBYUBLNFSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 229960000554 metrizamide Drugs 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000007127 saponification reaction Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 3
- CZEVAMMETWVBOD-UHFFFAOYSA-N 2-(carboxymethylsulfanylmethylsulfanyl)acetic acid Chemical compound OC(=O)CSCSCC(O)=O CZEVAMMETWVBOD-UHFFFAOYSA-N 0.000 description 2
- XOXRMRCXCQPIEF-UHFFFAOYSA-N 2-[2-(carboxymethylsulfanyl)ethoxy]acetic acid Chemical compound OC(=O)COCCSCC(O)=O XOXRMRCXCQPIEF-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- SHWNNYZBHZIQQV-UHFFFAOYSA-J EDTA monocalcium diisodium salt Chemical compound [Na+].[Na+].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O SHWNNYZBHZIQQV-UHFFFAOYSA-J 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000000370 acceptor Substances 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 125000005103 alkyl silyl group Chemical group 0.000 description 2
- 150000003931 anilides Chemical class 0.000 description 2
- 150000001559 benzoic acids Chemical class 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000013256 coordination polymer Substances 0.000 description 2
- 150000001991 dicarboxylic acids Chemical class 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 150000002531 isophthalic acids Chemical class 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229940037001 sodium edetate Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- 238000007487 urography Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- JEUVUETXSDIHIE-UHFFFAOYSA-N 2,4,6-triiodo-5-(2-methyl-3,5-dioxothiomorpholin-4-yl)benzene-1,3-dicarbonyl chloride Chemical compound O=C1C(C)SCC(=O)N1C1=C(I)C(C(Cl)=O)=C(I)C(C(Cl)=O)=C1I JEUVUETXSDIHIE-UHFFFAOYSA-N 0.000 description 1
- CRVYPNHLIAWRNV-UHFFFAOYSA-N 2,4,6-triiodobenzoic acid Chemical class OC(=O)C1=C(I)C=C(I)C=C1I CRVYPNHLIAWRNV-UHFFFAOYSA-N 0.000 description 1
- JUVHQPRUPDZMOJ-UHFFFAOYSA-N 2-(2-chloro-2-oxoethyl)sulfanylpropanoyl chloride Chemical compound ClC(=O)C(C)SCC(Cl)=O JUVHQPRUPDZMOJ-UHFFFAOYSA-N 0.000 description 1
- CCQMORVULNZXIA-UHFFFAOYSA-N 2-[2-(carboxymethylsulfanyl)ethylsulfanyl]acetic acid Chemical compound OC(=O)CSCCSCC(O)=O CCQMORVULNZXIA-UHFFFAOYSA-N 0.000 description 1
- YYQVDRBXQVJUHE-UHFFFAOYSA-N 2-[4-(carboxymethylsulfanyl)butylsulfanyl]acetic acid Chemical compound OC(=O)CSCCCCSCC(O)=O YYQVDRBXQVJUHE-UHFFFAOYSA-N 0.000 description 1
- LDOMKUVUXZRECL-UHFFFAOYSA-N 2-aminobenzene-1,3-dicarboxylic acid Chemical compound NC1=C(C(O)=O)C=CC=C1C(O)=O LDOMKUVUXZRECL-UHFFFAOYSA-N 0.000 description 1
- QEKPBYCXURULNE-UHFFFAOYSA-N 2-aminopropane-1,1-diol Chemical compound CC(N)C(O)O QEKPBYCXURULNE-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- YCLSOMLVSHPPFV-UHFFFAOYSA-N 3-(2-carboxyethyldisulfanyl)propanoic acid Chemical compound OC(=O)CCSSCCC(O)=O YCLSOMLVSHPPFV-UHFFFAOYSA-N 0.000 description 1
- ODJQKYXPKWQWNK-UHFFFAOYSA-L 3-(2-carboxylatoethylsulfanyl)propanoate Chemical compound [O-]C(=O)CCSCCC([O-])=O ODJQKYXPKWQWNK-UHFFFAOYSA-L 0.000 description 1
- DTUPXKKCESZNHW-UHFFFAOYSA-N 3-[(3-chloro-3-oxopropyl)-dimethylsilyl]propanoyl chloride Chemical compound ClC(=O)CC[Si](C)(C)CCC(Cl)=O DTUPXKKCESZNHW-UHFFFAOYSA-N 0.000 description 1
- UPZCIAVCFJRASZ-UHFFFAOYSA-N 3-[(3-chloro-3-oxopropyl)sulfanylmethylsulfanyl]propanoyl chloride Chemical compound ClC(=O)CCSCSCCC(Cl)=O UPZCIAVCFJRASZ-UHFFFAOYSA-N 0.000 description 1
- GBWOXZNEMWSIQQ-UHFFFAOYSA-N 3-[2-carboxyethyl(dimethyl)silyl]propanoic acid Chemical compound OC(=O)CC[Si](C)(C)CCC(O)=O GBWOXZNEMWSIQQ-UHFFFAOYSA-N 0.000 description 1
- JQHVZZNZAQIBJG-UHFFFAOYSA-N 3-[[(3-chloro-3-oxopropyl)-dimethylsilyl]oxy-dimethylsilyl]propanoyl chloride Chemical compound ClC(=O)CC[Si](C)(C)O[Si](C)(C)CCC(Cl)=O JQHVZZNZAQIBJG-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- QTMABVHHNMCWDA-UHFFFAOYSA-N 4-[3-carboxypropyl(dimethyl)silyl]butanoic acid Chemical compound OC(=O)CCC[Si](C)(C)CCCC(O)=O QTMABVHHNMCWDA-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- RPCKUDUZHDDTNR-UHFFFAOYSA-N Cl.Cl.OC(=O)CC[Si](C)(C)O[Si](C)(C)CCC(O)=O Chemical compound Cl.Cl.OC(=O)CC[Si](C)(C)O[Si](C)(C)CCC(O)=O RPCKUDUZHDDTNR-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000005422 Foreign-Body reaction Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 206010073734 Microembolism Diseases 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- RXDLGFMMQFNVLI-UHFFFAOYSA-N [Na].[Na].[Ca] Chemical compound [Na].[Na].[Ca] RXDLGFMMQFNVLI-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- FDQSRULYDNDXQB-UHFFFAOYSA-N benzene-1,3-dicarbonyl chloride Chemical compound ClC(=O)C1=CC=CC(C(Cl)=O)=C1 FDQSRULYDNDXQB-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000013276 bronchoscopy Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 239000012045 crude solution Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical group [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 230000010102 embolization Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- VVDGWALACJEJKG-UHFFFAOYSA-N iodamide Chemical compound CC(=O)NCC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I VVDGWALACJEJKG-UHFFFAOYSA-N 0.000 description 1
- 229960004901 iodamide Drugs 0.000 description 1
- 150000002497 iodine compounds Chemical class 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000002587 lymphangiography Methods 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- 229940100573 methylpropanediol Drugs 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000009608 myelography Methods 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000010491 poppyseed oil Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 150000000000 tetracarboxylic acids Chemical class 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 150000003628 tricarboxylic acids Chemical class 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000003966 vascular damage Effects 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C391/00—Compounds containing selenium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0834—Compounds having one or more O-Si linkage
- C07F7/0838—Compounds with one or more Si-O-Si sequences
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19792926428 DE2926428A1 (de) | 1979-06-28 | 1979-06-28 | Trijodierte 5-aminoisophthalsaeure- derivate |
| DE19792943777 DE2943777A1 (de) | 1979-10-26 | 1979-10-26 | Trijodierte 5-aminoisophthalsaeure-derivate |
| DE19803017304 DE3017304A1 (de) | 1980-05-02 | 1980-05-02 | Trijodierte 5-aminoisophthalsaeure-derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD151748A5 true DD151748A5 (de) | 1981-11-04 |
Family
ID=27188097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD80222179A DD151748A5 (de) | 1979-06-28 | 1980-06-26 | Verfahren zur herstellung von trijodierten 5-aminoisophtalsaeure-derivaten |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4367216A (no) |
| EP (1) | EP0022056B1 (no) |
| AU (1) | AU532175B2 (no) |
| CA (1) | CA1160243A (no) |
| DD (1) | DD151748A5 (no) |
| DE (1) | DE3063966D1 (no) |
| DK (1) | DK273280A (no) |
| ES (1) | ES8104795A1 (no) |
| FI (1) | FI802054A (no) |
| GR (1) | GR69655B (no) |
| IE (1) | IE49948B1 (no) |
| IL (1) | IL60416A (no) |
| NO (1) | NO151005C (no) |
| PH (1) | PH15404A (no) |
| PT (1) | PT71462A (no) |
| YU (1) | YU167680A (no) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3731542A1 (de) * | 1987-09-17 | 1989-03-30 | Schering Ag | Neue dicarbonsaeure-bis(3,5-dicarbamoyl-2,4,6-triiod-anilide), verfahren zu deren herstellung sowie diese enthaltende roentgenkontrastmittel |
| US5114703A (en) * | 1989-05-30 | 1992-05-19 | Alliance Pharmaceutical Corp. | Percutaneous lymphography using particulate fluorocarbon emulsions |
| IT1252180B (it) * | 1991-12-10 | 1995-06-05 | Bracco Ind Chimica Spa | 5,5'-(1,3-propandiil) bis (imino (2-osso-2,1-etandiil)acetilimino)-bis(2,4,6-triiodo-1,3-benzendicarbossiamidi),loro metodo di preparazione e mezzi di contrasto roentgenografici che li contengono |
| US5460798A (en) * | 1992-06-22 | 1995-10-24 | Barnett; Patrick A. | System for determining the quantity and identity of material ingested by user |
| FR2700696B1 (fr) * | 1993-01-28 | 1995-04-07 | Atta | Dispersions, émulsions, microémulsions, gels et compositions à usage biomédical comprenant un composé organique fluoré iodé, utilisables notamment comme agent de contraste. |
| US6694163B1 (en) | 1994-10-27 | 2004-02-17 | Wake Forest University Health Sciences | Method and system for producing interactive, three-dimensional renderings of selected body organs having hollow lumens to enable simulated movement through the lumen |
| US5920319A (en) * | 1994-10-27 | 1999-07-06 | Wake Forest University | Automatic analysis in virtual endoscopy |
| US5782762A (en) * | 1994-10-27 | 1998-07-21 | Wake Forest University | Method and system for producing interactive, three-dimensional renderings of selected body organs having hollow lumens to enable simulated movement through the lumen |
| US6331116B1 (en) | 1996-09-16 | 2001-12-18 | The Research Foundation Of State University Of New York | System and method for performing a three-dimensional virtual segmentation and examination |
| US7486811B2 (en) * | 1996-09-16 | 2009-02-03 | The Research Foundation Of State University Of New York | System and method for performing a three-dimensional virtual examination of objects, such as internal organs |
| US7194117B2 (en) * | 1999-06-29 | 2007-03-20 | The Research Foundation Of State University Of New York | System and method for performing a three-dimensional virtual examination of objects, such as internal organs |
| US8682045B2 (en) * | 1997-02-25 | 2014-03-25 | Wake Forest University Health Sciences | Virtual endoscopy with improved image segmentation and lesion detection |
| DE19728954C1 (de) * | 1997-06-30 | 1999-04-22 | Schering Ag | Saccharid-Konjugate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung |
| DE19740403C2 (de) * | 1997-09-09 | 1999-11-11 | Schering Ag | Neue Kontrastmittel |
| CA2352671A1 (en) | 1998-11-25 | 2000-06-08 | Wake Forest University | Virtual endoscopy with improved image segmentation and lesion detection |
| US7356367B2 (en) * | 2000-06-06 | 2008-04-08 | The Research Foundation Of State University Of New York | Computer aided treatment planning and visualization with image registration and fusion |
| US7706600B2 (en) | 2000-10-02 | 2010-04-27 | The Research Foundation Of State University Of New York | Enhanced virtual navigation and examination |
| AU2002245169A1 (en) | 2000-11-10 | 2002-07-08 | Wm. Marsh Rice University | Fullerene (c60)-based x-ray contrast agent for diagnostic imaging |
| US7630750B2 (en) * | 2001-02-05 | 2009-12-08 | The Research Foundation For The State University Of New York | Computer aided treatment planning |
| US7324104B1 (en) | 2001-09-14 | 2008-01-29 | The Research Foundation Of State University Of New York | Method of centerline generation in virtual objects |
| US7596256B1 (en) | 2001-09-14 | 2009-09-29 | The Research Foundation For The State University Of New York | Computer assisted detection of lesions in volumetric medical images |
| EP2014708A1 (en) | 2005-01-13 | 2009-01-14 | Cinvention Ag | Shaped body made of a composite material |
| US20100260390A1 (en) * | 2005-11-30 | 2010-10-14 | The Research Foundation Of State University Of New York | System and method for reduction of false positives during computer aided polyp detection |
| WO2007064980A2 (en) * | 2005-11-30 | 2007-06-07 | The Research Foundation Of State University Of New York | Electronic colon cleansing method for virtual colonoscopy |
| US20080213611A1 (en) * | 2007-01-19 | 2008-09-04 | Cinvention Ag | Porous, non-degradable implant made by powder molding |
| WO2008104599A1 (en) * | 2007-02-28 | 2008-09-04 | Cinvention Ag | High surface cultivation system bag |
| US20080213742A1 (en) * | 2007-02-28 | 2008-09-04 | Cinvention Ag | High surface cultivation system |
| US9512072B2 (en) * | 2013-10-31 | 2016-12-06 | Case Western Reserve University | Biodegradable computed tomography contrast agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD104193A5 (no) * | 1972-12-22 | 1974-03-05 | ||
| DE2628517C2 (de) * | 1976-06-23 | 1985-02-21 | Schering AG, 1000 Berlin und 4709 Bergkamen | Dicarbonsäure-bis(3,5-dicarbamoyl-2,4,6-trijodanilid)-Verbindungen, Verfahren zu ihrer Herstellung und Röntgenkontrastmittel |
| CH626873A5 (no) * | 1977-03-28 | 1981-12-15 | Bracco Ind Chimica Spa |
-
1980
- 1980-06-25 DK DK273280A patent/DK273280A/da not_active Application Discontinuation
- 1980-06-26 NO NO801916A patent/NO151005C/no unknown
- 1980-06-26 DD DD80222179A patent/DD151748A5/de unknown
- 1980-06-26 GR GR62306A patent/GR69655B/el unknown
- 1980-06-26 PT PT71462A patent/PT71462A/pt unknown
- 1980-06-26 YU YU01676/80A patent/YU167680A/xx unknown
- 1980-06-27 EP EP80730044A patent/EP0022056B1/de not_active Expired
- 1980-06-27 DE DE8080730044T patent/DE3063966D1/de not_active Expired
- 1980-06-27 FI FI802054A patent/FI802054A/fi not_active Application Discontinuation
- 1980-06-27 ES ES492891A patent/ES8104795A1/es not_active Expired
- 1980-06-27 US US06/163,895 patent/US4367216A/en not_active Expired - Lifetime
- 1980-06-27 IL IL60416A patent/IL60416A/xx unknown
- 1980-06-27 CA CA000355018A patent/CA1160243A/en not_active Expired
- 1980-06-27 IE IE1336/80A patent/IE49948B1/en not_active IP Right Cessation
- 1980-06-27 PH PH24209A patent/PH15404A/en unknown
- 1980-06-30 AU AU59769/80A patent/AU532175B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| IE801336L (en) | 1980-12-28 |
| EP0022056B1 (de) | 1983-06-29 |
| NO801916L (no) | 1980-12-29 |
| NO151005B (no) | 1984-10-15 |
| AU532175B2 (en) | 1983-09-22 |
| GR69655B (no) | 1982-07-07 |
| PT71462A (en) | 1980-07-01 |
| YU167680A (en) | 1983-02-28 |
| EP0022056A2 (de) | 1981-01-07 |
| CA1160243A (en) | 1984-01-10 |
| DK273280A (da) | 1980-12-29 |
| NO151005C (no) | 1985-01-23 |
| ES492891A0 (es) | 1981-05-16 |
| ES8104795A1 (es) | 1981-05-16 |
| IL60416A0 (en) | 1980-09-16 |
| IE49948B1 (en) | 1986-01-22 |
| EP0022056A3 (en) | 1981-03-25 |
| US4367216A (en) | 1983-01-04 |
| DE3063966D1 (en) | 1983-08-04 |
| PH15404A (en) | 1982-12-24 |
| FI802054A (fi) | 1980-12-29 |
| IL60416A (en) | 1983-12-30 |
| AU5976980A (en) | 1981-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0022056B1 (de) | Dimere trijodierte Isophthalsäurediamide, deren Herstellung, diese enthaltendes Röntgenkontrastmittel, und dimere trijodierte Isophthalsäure-chloride | |
| DE69434260T2 (de) | Hepatobillianische magnetische Resonanz-Kontrastmittel | |
| DE2628517C2 (de) | Dicarbonsäure-bis(3,5-dicarbamoyl-2,4,6-trijodanilid)-Verbindungen, Verfahren zu ihrer Herstellung und Röntgenkontrastmittel | |
| EP0049745B1 (de) | Neue N-Hydroxy-alkylierte Dicarbonsäure-bis-(3,5-dicarbamoyl-2,4,6-trijodanilide), deren Herstellung und diese enthaltende Röntgenkontrastmittel | |
| EP0130934A1 (de) | Neue Komplexbildner, Komplexe und Komplexsalze | |
| CH630064A5 (de) | Verfahren zur herstellung von jodhaltigen isophthalamidderivaten. | |
| DE2523567A1 (de) | Kontrastmittel fuer roentgenaufnahmen | |
| EP0022744B1 (de) | Trijodierte Basen, deren Herstellung und diese enthaltendes Röntgenkontrastmittel | |
| EP0426610B1 (de) | Nichtionisches Röntgenkontrastmittel mit hohem Jodgehalt | |
| EP0317492B1 (de) | Neue substituierte Dicarbonsäure-bis(3,5-dicarbamoyl-2,4,6-triiodanilide), Verfahren zu deren Herstellung sowie diese enthaltende Röntgenkontrastmittel | |
| EP0185130B1 (de) | Neue Derivate der 5-Alkoxy-2,4,6-trijod- und tribrom-isophthalsäure, Verfahren zu ihrer Herstellung und diese enthaltende Röntgenkontrastmittel | |
| DE69214934T2 (de) | Nichtionische jodhaltige röntgenstrahlenkontrastmittel, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen | |
| DE69213768T2 (de) | 5,5'-[(1,3-propandiyl)bis-[imino(2-oxo-2,1-ethandiyl)acetylimino]]bis(2,4,6-triiodo-1,3-benzenedicarboxyamide), und diese verbindungen enthaltendes kontrastmittel | |
| DE2926428A1 (de) | Trijodierte 5-aminoisophthalsaeure- derivate | |
| DE2216627C3 (de) | 2,4,6-Trijodbenzoe säurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Röntgenkontrastmittel | |
| DE3044814A1 (de) | Unsymmetrisch substituierte dicarbonsaeure-bis-(2,4,6-trijod-anilide), deren herstellung und diese enthaltende roentgenkontrastmittel | |
| DE2943777A1 (de) | Trijodierte 5-aminoisophthalsaeure-derivate | |
| CH420191A (de) | Verfahren zur Herstellung von jodierten Acylaminobenzoesäureamiden und Verwendung derselben als schattengebende Komponente in Röntgenkontrastmitteln | |
| DE3017304A1 (de) | Trijodierte 5-aminoisophthalsaeure-derivate | |
| DE939507C (de) | Verfahren zur Herstellung von Bis-(ª‰-chloraethyl)-aminen | |
| DE1695835B2 (de) | 2-Benzyloxybenzamide, diese enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung | |
| DE218389C (no) | ||
| DE3420387A1 (de) | 2-(4-biphenylyl)-4-hexenonsaeure und ihre derivate mit entzuendungshemmender wirksamkeit | |
| DE19740403C2 (de) | Neue Kontrastmittel | |
| AT317196B (de) | Verfahren zur Herstellung neuer 1-Benzoyloxy-2-niedrig-alkylaminobenzocycloalkanderivate |